Tissue damage & immune response

Service description

Acquiring information on the immunogenic properties of a drug prior to clinical trials may be essential to avoid risks to the patient. Immunogenicity is a much more complex problem and the immunogenicity of a drug goes beyond its ability to generate antibodies (antigenicity) through other immune pathways. In this expertise, you can test the immunogenicity of your drug under in vitro conditions.